Skip to main content
New Microbes and New Infections logoLink to New Microbes and New Infections
letter
. 2016 Jul 29;14:6–7. doi: 10.1016/j.nmni.2016.07.006

Compared lethality rates of Clostridium difficile infections at the local, regional and national levels in France

M Huart 1,2, C Abat 3, MT Jimeno 4, X Deparis 2, D Raoult 1, P-E Fournier 1,3,
PMCID: PMC5009227  PMID: 27621820

Dear Sir,

In December 2013, we reported a Clostridium difficile (CD) outbreak caused by the hyper-virulent ribotype 027 in the Provence-Alpes-Côte d’Azur (PACA) area, southeastern France [1]. Sixty-one patients were hospitalized from March 2013 to April 2014 in the four university hospitals of Marseille (Timone, Conception, North and Sainte-Marguerite) for CD 027 infection, with a mortality of 43% [2]. Following this outbreak, we developed an automated epidemiological surveillance system for CD cases.

Cloatridium difficile is associated with an elevated lethality worldwide [2], [3], [4]. This lethality has gradually increased, exceeding that of many other bacterial species. In the present retrospective study, from January 2012 to December 2015, we compared the lethality rates of CD isolated in enterocolitis and the three most common bacterial pathogens isolated from any specimen (Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa) in the university hospitals of Marseille, in the PACA area, France. The analysed data include the numbers of patients infected by each of the four above-mentioned bacterial species and the associated lethality for patients over 65 years old. The data at the Marseille and regional levels were obtained using our epidemiological surveillance system whereas national data were obtained by the medical information service in Timone hospital (National Data obtained by Convention de droit d’usage des données PMSI, N°d’agrément 2015-111111-88-46). Duplicates were removed. For a given patient, only the first infection caused by a given microorganism was registered. We calculated the annual lethality rates (for the years 2012 to 2015) by dividing the number of deaths by the number of patients affected by the respective bacterial species by each year. All data collection and descriptive epidemiological analyses were performed in Excel.

Within Marseille university hospitals, we observed a stable lethality rate of E. coli urinary-tract infections between 2012 and 2015 (3.6%–5.6%, Table 1). For E. coli bacteraemia, the lethality increased from 2012 to 2014 (11.8%–18.3%, Table 1) and decreased in 2015 (10.7%). For S. aureus bacteraemia, the lethality decreased constantly from 22.9% in 2012 to 19.1% in 2014 (Table 1) then increased in 2015 (20.3%). For P. aeruginosa bacteraemia the lethality increased from 2012 (28.6%) to 2013 (31.7%), then decreased in 2014 (23.1%) and increased in 2015 (30.4%; Table 1). The CD lethality rate was lower in 2012 (10.6%) than in other years and reached a peak of 18.3% in 2013 (1.7-fold increase) and then decreased in 2014 (17.9%) and 2015 (12.4%).

Table 1.

Number of deaths and lethality rate of infection caused by Clostridium difficile and the three most common bacterial pathogens in Marseille university Hospitals, Provence-Alpes-Côte d’Azur region and France from January 2012 to December 2015

Bacterial species Marseille University Hospitals
PACA Region
France
Numbera of patients Number of deaths Lethality rate Number of patients Number of deaths Lethality rate Number of patients Number of deaths Lethality rate
2012
Global mortalityb 30 890 1581 5.1 339 182 19 037 5.6 3 502 943 215 945 6.2
Clostridium difficile 47 5 10.6 566 86 15.2 7500 1288 17.2
Escherichia coli bacteraemia 136 16 11.8 1146 298 26.0 10 752 2575 23.9
Escherichia coli UTI 380 21 5.5 8 562 688 8.0 97 357 5891 6.1
Staphylococcus aureus bacteraemia 105 24 22.9 660 238 36.1 8131 2539 31.2
Pseudomonas aeruginosa bacteraemia 28 8 28.6 324 131 40.4 3028 1176 38.8
2013
Global mortalityb 31 723 1583 5.0 347 520 19 220 5.5 3 588 311 215 303 6.0
Clostridium difficile 142* 26* 18.3 710 142 20.0 8461 1511 17.9
Escherichia coli bacteraemia 133 22 16.5 1201 313 26.1 11 574 2923 25.3
Escherichia coli UTI 478 17 3.6 9023 642 7.1 103 746 6549 6.3
Staphylococcus aureus bacteraemia 104 21 20.2 687 222 32.3 7988 2669 33.4
Pseudomonas aeruginosa bacteraemia 41 13 31.7 333 122 36.6 3155 1168 37.0
2014
Global mortalityb 32 335 1559 4.8 356 108 19 427 5.5 3 695 116 216 734 5.9
Clostridium difficile 148 27 18.2 914 175 19.1 8883 1580 17.8
Escherichia coli bacteraemia 197 36 18.3 1365 310 22.7 13 069 3095 23.7
Escherichia coli UTI 534 29 5.4 9679 733 7.6 110 565 6939 6.3
Staphylococcus aureus bacteraemia 173 33 19.1 771 269 34.9 8350 2774 33.2
Pseudomonas aeruginosa bacteraemia 52 12 23.1 404 126 31.2 3325 1158 34.8
2015
Global mortalityb 32 555 1645 5.1 N/A N/A N/A 3 836 118 229 608 6.0
Clostridium difficile 153* 19* 12.4 N/A N/A N/A 11 336 1972 17.4
Escherichia coli bacteraemia 242 26 10.7 N/A N/A N/A 21 901 4152 19.0
Escherichia coli UTI 1 111 62 5.6 N/A N/A N/A 114 962 7507 6.5
Staphylococcus aureus bacteraemia 143 29 20.3 N/A N/A N/A 11 481 3608 31.4
Pseudomonas aeruginosa bacteraemia 56 17 30.4 N/A N/A N/A 4301 1483 34.5

UTI, urinary tract infection.

*p 0.09, not significant.

a

National Data obtained by: Convention de droit d’usage des données PMSI, N°d’agrément 2015-111111-88-46.

b

Includes all causes of death, infectious or not.

At the PACA level, in 2012, 2013 and 2014, the lethality rate of CD infections was also lower than those of other pathogens (Table 1). At the country level, the highest lethality rate in 2012 and 2013 was that of P. aeruginosa, which was slightly higher than that of C. difficile.

When considering the evolution of lethality rates over time (Table 1), we observed that CD-related mortality had the greatest variation among bacterial pathogens in Marseille and PACA, which may be explained by the 2013–2014 CD 027 outbreak [2]. We also observed a great reduction in CD-related lethality in 2015, although non-significant (two-sided Pearson’s chi-square test, p 0.09). This reduction followed the implementation of systematic faecal microbiota transplantation for patients hospitalized in Marseille university hospitals with CD 027 infections [2].

Together, these results confirmed that CD is a major life-threatening bacterial pathogen, especially for the elderly, like P. aeruginosa. This confirms what was previously observed in our region [1], [5] and also in northern France and other countries [6], [7]. The rapid decrease in the lethality of CD infections in Marseille university hospitals (18.3% to 12.4%) and the PACA region can be explained by the introduction of new treatment for all patients in PACA, the faecal microbiota transplantation [5].

Our study demonstrated that the CD-related lethality was similar in Marseille university hospitals and at the regional and national levels and was lower than those caused by P. aeruginosa or S. aureus. CD remains a major public health concern. Moreover, our results should encourage hospitals to extensively survey CD infections by the implementation of automatic monitoring systems, and also by developing rapid screening procedures to identify and isolate infected patients and healthy carriers upon hospitalization.

References

  • 1.Lagier J.-C., Dubourg G., Cassir N., Fournier P.-E., Colson P., Richet H. Clostridium difficile 027 emerging outbreak in Marseille, France. Infect Control Hosp Epidemiol. 2013;34:1339–1341. doi: 10.1086/673995. [DOI] [PubMed] [Google Scholar]
  • 2.Lagier J.-C., Delord M., Million M., Parola P., Stein A., Brouqui P. Dramatic reduction in Clostridium difficile ribotype 027-associated mortality with early fecal transplantation by the nasogastric route: a preliminary report. Eur J Clin Microbiol Infect Dis. 2015;34:1597–1601. doi: 10.1007/s10096-015-2394-x. [DOI] [PubMed] [Google Scholar]
  • 3.Burke K.E., Lamont J.T. Clostridium difficile infection: a worldwide disease. Gut Liver. 2014;8:1–6. doi: 10.5009/gnl.2014.8.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Gabriel B. Gabriel Birgand—Pharmacien Hygiéniste—Epidémiologiste; 2011. Dynamique des souches de Clostridium difficile en Europe.http://www.gabrielbirgand.fr/2011/09/dynamique-des-souches-de-clostridium-difficile-en-europe/ [Internet] Available from: [Google Scholar]
  • 5.Kuijper E.J., Barbut F., Brazier J.S., Kleinkauf N., Eckmanns T., Lambert M.L. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2008;13(31) [PubMed] [Google Scholar]
  • 6.Mascart G., Delmée M., Van Broeck J., Cytryn E., Karmali R., Cherifi S. Impact of ribotype 027 on Clostridium difficile infection in a geriatric department. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. 2013;32:1177–1182. doi: 10.1007/s10096-013-1864-2. [DOI] [PubMed] [Google Scholar]
  • 7.Lessa F.C., Gould C.V., McDonald L.C. Current status of Clostridium difficile infection epidemiology. Clin Infect Dis Off Publ Infect Dis Soc Am. 2012;55(Suppl. 2):S65–S70. doi: 10.1093/cid/cis319. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from New Microbes and New Infections are provided here courtesy of Elsevier

RESOURCES